BLGO
BioLargo, Inc. · Basic Materials · Specialty Chemicals
$0.08
0.00% today · -11.11% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- BLGO 0.00% on the last session vs SPY +0.74%: −0.7 pts of stock-specific move.
- Aftermath, big drop (Sep 29): After its 76 big drops in the past 5 years, BLGO typically gained 0.0% over the next week (median) and was higher only 43% of the time; half the outcomes fell between -5.3% and +6.3%. An ordinary week: +0.0%. Among S&P 500 stocks after big drops, that ranks #297 of 500.
- 1 Reddit mentions in the past 24 hours, 67% positive over the week.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Mentions · past hour
1
+1100% vs the day's pace
Mentions · 24 hours
1
-22% vs the week's pace
Mentions · 7 days
9
67% positive
Avg sentiment · 24h
-0.662
per mention, −1 to +1
What Reddit is saying
No summary in the past day.
Top comments, summarized
Most recent
$BLGO - Keep an eye on it
ONE OF MANY
**"The people closest to every contract, every lab result, and every cash-flow number …
- **"The people closest to every contract, every lab result, and every cash-flow number have watched this stock fall eighty percent and decided their own money isn't touching this shit.
1 day ago
$BLGO ViaCLYR is commercial now, BioClynse is next, and Clyra's $100M value was paid for - not imagined
$BLGO latest Form 4 matters: CEO Dennis Calvert knows best about what is happening behind the curtai…
- $BLGO latest Form 4 matters: CEO Dennis Calvert knows best about what is happening behind the curtains and he just took 931,886 shares at $0.08 for accrued salary/expenses--not cash--and they are locked until BLGO reaches $40M in revenue, a $300M market cap, or a change of control.
- This follows his latest annual compensation award-- no cash but 919,483 shares--under the same lock-up framework.
- That does not guarantee results, but it does show management is accepting restricted equity rather than cash and tying its upside to meaningful execution.
- At today's \~$25.7M market cap, the $300M unlock is \~11.7x, or roughly $0.94/share.
- It means that he won't see a penny until those benchmarks of \~ 10X in revenue or \~ 12x in market cap are reached.
4 days ago
$BLGO - Keep an eye on it
Ok.
Lies and misleading are:
\- \*\*"Insiders won't put their own money in." False.\*\* Calvert …
- Misleading.\*\* The post treats historical consolidated cash use as a precise ongoing runway.
- False as a company-wide claim.\*\* Clyra has distribution agreements, and BioLargo has disclosed engineering contracts.
- Misleading.\*\* Management tied that indicative figure to outside investors' private Clyra transactions.
- Misleading.\*\* Losing Pooph drove the year-over-year decline; Q2 revenue also grew 12% sequentially.
- Misleading.\*\* Pooph owned the brand; BioLargo supplied technology and product.
$BLGO - Keep an eye on it
\> What if it is all real this time and they'll deliver in time or are even a few steps further than…
- But the current landscape of retail investors is full of folks who already did that and now regret it (and I'm admittedly one of them), so I can't in good conscience recommend others follow suit.
- People bought back in 2024 because someone told them blast-off news was right around the corner, and when that didn't materialize, they lost interest and sold.
- Personally, I think trying to convince people to buy now (before the thesis is proven out) sounds a lot like a bagholder trying to create exit liquidity for himself, and folks are wary of that sort of thing.
- If the Cinderella story plays out, new investors will have an opportunity to get in on the 2nd floor, and all those "most convicted holders" will be elated as well... Everybody wins.
- I don't know what "heavily" means to you, but less than $5k has traded today as of this writing and it's up 7%, so you could probably gobble up the ASK through $0.12 pretty easily if you wanted.
$BLGO - Keep an eye on it
This helps. Thanks. I certainly agree with your suggestion to put it on the watchlist not to miss w…
- I certainly agree with your suggestion to put it on the watchlist not to miss when the big turnaround will happen.
- BTW I strongly disagree that longtime holders will automatically hand new investors an easy entry at $0.15.
- People who have followed BioLargo for 3, 5, 10 or 15 years aren't all waiting for the first bounce so they can break even.
- If Clyra's launch becomes real, why would the most convicted holders sell at $0.15 just as the path to a much larger valuation comes into view?
- That's the bullish case: not that success is guaranteed, but that waiting until everyone agrees it's happening may mean missing the moment when the market reassesses BLGO.
$BLGO - Keep an eye on it
My AI reverse engineered that prompt.
Just to show you that it did not get to the same conclusion …
- Focus on the Pooph licensing and payment dispute; the change in quarterly revenue; June 30 cash, operating cash burn, working capital, and stockholders' equity; outstanding warrants and likely financing needs; Clyra Medical's ownership and management's stated valuation; and whether insiders have made open-market purchases.
- **Write a bearish investment takedown titled "My AI Slop Analysis: BLGO -- BioLargo, Inc." Open with a one-line verdict.
- Make the argument feel like a sharp, frustrated retail investor explaining why the stock is dangerous--not a neutral analyst report.
- Use specific figures, dates, calculations, and parenthetical references to SEC filings.
- Write in punchy paragraphs with occasional profanity, vivid phrasing, and an unequivocal final verdict of "HARD AVOID."
Day by day
| Date | Close | Change | R500 | Mentions | Positive | Upvotes | Voted sentiment |
|---|---|---|---|---|---|---|---|
| Sat Oct 03 | 1 | 1 | 1 | 0.9 | |||
| Fri Oct 02 | 0.08 | -1.50% | #455 | 0 | |||
| Thu Oct 01 | 0.08 | 0.00% | #298 | 3 | 1 | 3 | -1.1 |
| Wed Sep 30 | 0.08 | 0.00% | #121 | 4 | 3 | 1 | -1.1 |
| Tue Sep 29 | 0.08 | -11.11% | #501 | 0 | |||
| Mon Sep 28 | 0.09 | 0.00% | #165 | 0 | |||
| Fri Sep 25 | 0.09 | 0.00% | #329 | 0 | |||
| Thu Sep 24 | 0.09 | 0.00% | #177 | 0 | |||
| Wed Sep 23 | 0.09 | 0.00% | #171 | 0 | |||
| Tue Sep 22 | 0.09 | 0.00% | #249 | 0 | |||
| Mon Sep 21 | 0.09 | 0.00% | #292 | 0 | |||
| Fri Sep 18 | 0.09 | 0.00% | #157 | 0 | |||
| Thu Sep 17 | 0.09 | 0.00% | #296 | 0 | |||
| Wed Sep 16 | 0.09 | 0.00% | #163 | 0 | |||
| Tue Sep 15 | 0.09 | -10.00% | #501 | 0 | |||
| Mon Sep 14 | 0.10 | 0.00% | #282 | 0 | |||
| Fri Sep 11 | 0.10 | 0.00% | #342 | 0 | |||
| Thu Sep 10 | 0.10 | 0.00% | #167 | 0 | |||
| Wed Sep 09 | 0.10 | 0.00% | #100 | 0 | |||
| Tue Sep 08 | 0.10 | +11.11% | #1 | 0 | |||
| Fri Sep 04 | 0.09 | 0.00% | #180 | 0 | |||
| Thu Sep 03 | 0.09 | -10.00% | #501 | 0 | |||
| Wed Sep 02 | 0.10 | +11.11% | #2 | 0 | |||
| Tue Sep 01 | 0.09 | -10.00% | #501 | 0 | |||
| Mon Aug 31 | 0.10 | 0.00% | #137 | 0 | |||
| Fri Aug 28 | 0.10 | 0.00% | #228 | 0 | |||
| Thu Aug 27 | 0.10 | -9.09% | #501 | 0 | |||
| Wed Aug 26 | 0.11 | 0.00% | #285 | 0 | |||
| Tue Aug 25 | 0.11 | 0.00% | #211 | 0 | |||
| Mon Aug 24 | 0.11 | +10.00% | #1 | 0 |